Covid19-Sources

4463 bookmarks
Newest
(3) A Marm Kilpatrick auf Twitter: "How do we get broad immunity to SARS-CoV-2 that will protect against future variants? 2 studies (are there more?) suggest that vaccination followed by infection gives broader protection than infection followed by vaccination. @florian_krammer @profshanecrotty @GuptaR_lab https://t.co/rqdf6rE9ej" / Twitter
(3) A Marm Kilpatrick auf Twitter: "How do we get broad immunity to SARS-CoV-2 that will protect against future variants? 2 studies (are there more?) suggest that vaccination followed by infection gives broader protection than infection followed by vaccination. @florian_krammer @profshanecrotty @GuptaR_lab https://t.co/rqdf6rE9ej" / Twitter
#twitter#vaccination
fsnestel·twitter.com·
(3) A Marm Kilpatrick auf Twitter: "How do we get broad immunity to SARS-CoV-2 that will protect against future variants? 2 studies (are there more?) suggest that vaccination followed by infection gives broader protection than infection followed by vaccination. @florian_krammer @profshanecrotty @GuptaR_lab https://t.co/rqdf6rE9ej" / Twitter
(2) Edward Nirenberg auf Twitter: "Because the N protein is *inside* the actual virus, antibodies directed against the N protein cannot target viral particles. It's thought that these antibodies occur because of the rupturing of infected cells leaking N protein where a B cell might find them and become activated." / Twitter
(2) Edward Nirenberg auf Twitter: "Because the N protein is *inside* the actual virus, antibodies directed against the N protein cannot target viral particles. It's thought that these antibodies occur because of the rupturing of infected cells leaking N protein where a B cell might find them and become activated." / Twitter
#twitter#n protein#antibodies
fsnestel·twitter.com·
(2) Edward Nirenberg auf Twitter: "Because the N protein is *inside* the actual virus, antibodies directed against the N protein cannot target viral particles. It's thought that these antibodies occur because of the rupturing of infected cells leaking N protein where a B cell might find them and become activated." / Twitter
(8) Eric Topol auf Twitter: "Side by side event curves for the original Pfizer vaccine trial vs the Booster trial You can see the curves diverge about a week earlier with a booster, ~14 vs 7 days, which aligns with much faster induction of neutralizing antibodies https://t.co/WhnZbjyIXj" / Twitter
(8) Eric Topol auf Twitter: "Side by side event curves for the original Pfizer vaccine trial vs the Booster trial You can see the curves diverge about a week earlier with a booster, ~14 vs 7 days, which aligns with much faster induction of neutralizing antibodies https://t.co/WhnZbjyIXj" / Twitter
#twitter#vaccination#booster#mRNA
fsnestel·twitter.com·
(8) Eric Topol auf Twitter: "Side by side event curves for the original Pfizer vaccine trial vs the Booster trial You can see the curves diverge about a week earlier with a booster, ~14 vs 7 days, which aligns with much faster induction of neutralizing antibodies https://t.co/WhnZbjyIXj" / Twitter
Waning of SARS-CoV-2 antibodies targeting the Spike protein in individuals post second dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and risk of breakthrough infections: analysis of the Virus Watch community cohort.
Waning of SARS-CoV-2 antibodies targeting the Spike protein in individuals post second dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and risk of breakthrough infections: analysis of the Virus Watch community cohort.
#paper#medrxiv#decay#antibodies#mRNA#vector#vaccination
fsnestel·medrxiv.org·
Waning of SARS-CoV-2 antibodies targeting the Spike protein in individuals post second dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and risk of breakthrough infections: analysis of the Virus Watch community cohort.